Peter Droppet also had some positive remarks and a short article available from his twitter feed (also linked in Sally's article) https://twitter.com/3NT
Its not specifically mentioned in Sally's article but the discussion does talk about the importance of going after the stomal layer which is exactly what PEG-PH20 (from Halozyme) does. I am cautiously optimistic that it will be a strong drug in pancreatic cancer if Abraxane ends up with good results. I posted a link to a preclincal paper (here or the Halo board) which had impressive results. They should be completing the dose randomization portion of the phase 1 (if haven't already) and be in the second part of the study. Hopefully there is an update at their R&D Day in a couple days.
Market Data 
Markets 
AI
